ATS core curriculum 2023. Pediatric pulmonary medicine: Respiratory disorders in infants.
bronchopulmonary dysplasia
central sleep apnea
diffuse lung disease
infants
obstructive sleep apnea
pulmonary hypertension
Journal
Pediatric pulmonology
ISSN: 1099-0496
Titre abrégé: Pediatr Pulmonol
Pays: United States
ID NLM: 8510590
Informations de publication
Date de publication:
28 Mar 2024
28 Mar 2024
Historique:
revised:
13
02
2024
received:
15
11
2023
accepted:
06
03
2024
medline:
28
3
2024
pubmed:
28
3
2024
entrez:
28
3
2024
Statut:
aheadofprint
Résumé
The American Thoracic Society Core Curriculum updates clinicians annually in pediatric pulmonary disease. This is a summary of the Pediatric Pulmonary Medicine Core Curriculum presented at the 2023 American Thoracic Society International Conference. The respiratory disorders of infancy discussed in this year's review include: the care of the patient with bronchopulmonary dysplasia in the neonatal intensive care unit, clinical phenotypes and comorbidities; diffuse lung disease; pulmonary hypertension; central and obstructive sleep apnea. The care of infants with respiratory disorders often poses significant challenges to the general pediatric pulmonologist, sleep clinician, and neonatologist. This review aims to highlight the most clinically relevant aspects of the evaluation, management, and outcomes of infants with these key respiratory disorders, while emphasizing the importance of multidisciplinary care. Furthermore, this document summarizes essential aspects of genetic testing, novel imaging and treatment modalities, and includes multiple resources for clinical practice.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : None
Informations de copyright
© 2024 Wiley Periodicals LLC.
Références
Bell EF, Hintz SR, Hansen NI, et al. Mortality, in‐hospital morbidity, care practices, and 2‐year outcomes for extremely preterm infants in the US, 2013‐2018. JAMA. 2022;327(3):248‐263. doi:10.1001/jama.2021.23580
Cristea AI, Ren CL, Amin R, et al. Outpatient respiratory management of infants, children, and adolescents with post‐prematurity respiratory disease: an official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2021;204(12):e115‐e133. doi:10.1164/rccm.202110‐2269ST
Cristea AI, Tracy MC, Bauer SE, et al. Approaches to interdisciplinary care for infants with severe bronchopulmonary dysplasia: a survey of the bronchopulmonary dysplasia collaborative. Am J Perinatol. Published online December 7, 2022. doi:10.1055/s‐0042‐1755589
Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163(7):1723‐1729. doi:10.1164/ajrccm.163.7.2011060
Jensen EA, Dysart K, Gantz MG, et al. The diagnosis of bronchopulmonary dysplasia in very preterm infants. An evidence‐based approach. Am J Respir Crit Care Med. 2019;200(6):751‐759. doi:10.1164/rccm.201812‐2348OC
Lee SM, Sie L, Liu J, Profit J, Lee HC. Evaluation of trends in bronchopulmonary dysplasia and respiratory support practice for very low birth weight infants: a population‐based cohort study. J Pediatr. 2022;243:47‐52. doi:10.1016/j.jpeds.2021.11.049
Northway Jr. WH, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline‐membrane disease. N Engl J Med. 1967;276(7):357‐368. doi:10.1056/NEJM196702162760701
Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res. 1999;46(6):641. doi:10.1203/00006450‐199912000‐00007
Trembath A, Laughon MM. Predictors of bronchopulmonary dysplasia. Clin Perinatol. 2012;39(3):585‐601. doi:10.1016/j.clp.2012.06.014
Greenberg RG, McDonald SA, Laughon MM, et al. Online clinical tool to estimate risk of bronchopulmonary dysplasia in extremely preterm infants. Archiv Dis Childhood‐Fetal Neonatal Edition. 2022;107:638‐643. doi:10.1136/archdischild‐2021‐323573
Abiramalatha T, Ramaswamy VV, Bandyopadhyay T, et al. Interventions to prevent bronchopulmonary dysplasia in preterm neonates: an umbrella review of systematic reviews and meta‐analyses. JAMA Pediatr. 2022;176(5):502‐516. doi:10.1001/jamapediatrics.2021.6619
Guthrie SO, Roberts KD. Less invasive surfactant administration methods: who, what and how. other. Published online September 22, 2023. doi:10.1038/s41372‐023‐01778‐2
Onland W, van de Loo M, Offringa M, van Kaam A. Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database Systematic Rev. 2023;3(3):CD010941. doi:10.1002/14651858.CD010941.pub3
Bassler D, Shinwell ES, Hallman M, et al. Long‐term effects of inhaled budesonide for bronchopulmonary dysplasia. N Engl J Med. 2018;378(2):148‐157. doi:10.1056/NEJMoa1708831
Nobile S, Di Sipio Morgia C, Hall M. Long‐term effects of intratracheal budesonide and surfactant for the prevention of bronchopulmonary dysplasia: a narrative review. Am J Perinatol. Published online June 6, 2023. doi:10.1055/s‐0043‐1769795
Abman SH, Collaco JM, Shepherd EG, et al. Interdisciplinary care of children with severe bronchopulmonary dysplasia. J Pediatr. 2017;181:12‐28. doi:10.1016/j.jpeds.2016.10.082
Schmidt B, Roberts RS, Davis P, et al. Long‐term effects of caffeine therapy for apnea of prematurity. N Engl J Med. 2007;357(19):1893‐1902. doi:10.1056/NEJMoa073679
Schmidt B, Roberts RS, Davis P, et al. Caffeine therapy for apnea of prematurity. N Engl J Med. 2006;354(20):2112‐2121. doi:10.1056/NEJMoa054065
Mürner‐Lavanchy IM, Doyle LW, Schmidt B, et al. Neurobehavioral outcomes 11 years after neonatal caffeine therapy for apnea of prematurity. Pediatrics. 2018;141(5):e20174047. doi:10.1542/peds.2017‐4047
Davis PG, Schmidt B, Roberts RS, et al. Caffeine for apnea of prematurity trial: benefits may vary in subgroups. J Pediatr. 2010;156(3):382‐387. doi:10.1016/j.jpeds.2009.09.069
Bruschettini M, Brattström P, Russo C, Onland W, Davis PG, Soll R. Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity. Cochrane Database Syst Rev. Published online April 11, 2023. doi:10.1002/14651858.CD013873.pub2
Li Z, Mu X, Dang D, et al. Comparison of lung ultrasound scores with clinical models for predicting bronchopulmonary dysplasia. Eur J Pediatr. 2023;182(4):1697‐1705. doi:10.1007/s00431‐023‐04847‐y
Oulego‐Erroz I, Alonso‐Quintela P, Terroba‐Seara S, Jiménez‐González A, Rodríguez‐Blanco S. Early assessment of lung aeration using an ultrasound score as a biomarker of developing bronchopulmonary dysplasia: a prospective observational study. J Perinatol. 2021;41(1):62‐68. doi:10.1038/s41372‐020‐0724‐z
Pezza L, Alonso‐Ojembarrena A, Elsayed Y, et al. Meta‐analysis of lung ultrasound scores for early prediction of bronchopulmonary dysplasia. Ann Am Thorac Soc. 2022;19(4):659‐667. doi:10.1513/AnnalsATS.202107‐822OC
Hysinger EB, Bates AJ, Higano NS, et al. Ultrashort echo‐time MRI for the assessment of tracheomalacia in neonates. Chest. 2020;157(3):595‐602. doi:10.1016/j.chest.2019.11.034
Soi HE, Higano N, Fleck R, Kingma PS, Woods JC. Neonatal pulmonary magnetic resonance imaging predicts respiratory outcomes through two years of life in bronchopulmonary dysplasia. 2020.
Higano NS, Spielberg DR, Fleck RJ, et al. Neonatal pulmonary magnetic resonance imaging of bronchopulmonary dysplasia predicts short‐term clinical outcomes. Am J Respir Crit Care Med. 2018;198(10):1302‐1311. doi:10.1164/rccm.201711‐2287OC
Shepherd EG, Lync SK, Neli LD. Management of severe BPD requiring chronic medical support. In: Pryhuber S, ed. Updates on Neonatal Chronic Lung Disease. Elsevier; 2020:269‐277.
Miller AN, Kielt MJ, El‐Ferzli GT, Nelin LD, Shepherd EG. Optimizing ventilator support in severe bronchopulmonary dysplasia in the absence of conclusive evidence. Front Pediatr. 2022;10:1022743. doi:10.3389/fped.2022.1022743
Yallapragada S, Savani RC, Mūnoz‐Blanco S, et al. Qualitative indications for tracheostomy and chronic mechanical ventilation in patients with severe bronchopulmonary dysplasia. J Perinatol. 2021;41(11):2651‐2657. doi:10.1038/s41372‐021‐01165‐9
Wu KY, Jensen EA, White AM, et al. Characterization of disease phenotype in very preterm infants with severe bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2020;201(11):1398‐1406. doi:10.1164/rccm.201907‐1342OC
Higano NS, Bates AJ, Gunatilaka CC, et al. Bronchopulmonary dysplasia from chest radiographs to magnetic resonance imaging and computed tomography: adding value. Pediatr Radiol. 2022;52(4):643‐660. doi:10.1007/s00247‐021‐05250‐1
Mourani PM, Mandell EW, Meier M, et al. Early pulmonary vascular disease in preterm infants is associated with late respiratory outcomes in childhood. Am J Respir Crit Care Med. 2019;199(8):1020‐1027. doi:10.1164/rccm.201803‐0428OC
Goss KN, Everett AD, Mourani PM, Baker CD, Abman SH. Addressing the challenges of phenotyping pediatric pulmonary vascular disease. Pulm Circ. 2017;7(1):7‐19. doi:10.1086/689750
Abman SH. Pulmonary hypertension: the hidden danger for newborns. Neonatology. 2021;118(2):211‐217. doi:10.1159/000516107
Mirza H, Mandell EW, Kinsella JP, McNamara PJ, Abman SH. Pulmonary vascular phenotypes of prematurity: the path to precision medicine. J Pediatr. 2023;259:113444. doi:10.1016/j.jpeds.2023.113444
Bhat R, Salas AA, Foster C, Carlo WA, Ambalavanan N. Prospective analysis of pulmonary hypertension in extremely low birth weight infants. Pediatrics. 2012;129(3):e682‐e689. doi:10.1542/peds.2011‐1827
Lagatta JM, Hysinger EB, Zaniletti I, et al. The impact of pulmonary hypertension in preterm infants with severe bronchopulmonary dysplasia through 1 year. J Pediatr. 2018;203:218‐224. doi:10.1016/j.jpeds.2018.07.035
Varghese N, Rios D. Pulmonary hypertension associated with bronchopulmonary dysplasia: a review. Pediatr Allergy Immunol Pulmonol. 2019;32(4):140‐148. doi:10.1089/ped.2018.0984
Hysinger EB. Central airway issues in bronchopulmonary dysplasia. Pediatr Pulmonol. 2021;56(11):3518‐3526. doi:10.1002/ppul.25417
Enzer KG, Wine TM, Gien J, Somme S, Prager JD, Baker CD. Posterior tracheopexy for preterm infants with severe bronchopulmonary dysplasia and severe tracheobronchomalacia: a case series. Pediatr Pulmonol. 2022;57(9):2279‐2281. doi:10.1002/ppul.26029
Monnier P. Applied surgical anatomy of the larynx and trachea. In: Monnier P, ed. Pediatric Airway Surgery. Springer; 2011.
Wallis C, Alexopoulou E, Antón‐Pacheco JL, et al. ERS statement on tracheomalacia and bronchomalacia in children. Eur Respir J. 2019;54(3):1900382. doi:10.1183/13993003.00382‐2019
Siboni S, Bonavina L, Rogers BD, et al. Effect of increased intra‐abdominal pressure on the esophagogastric junction: a systematic review. J Clin Gastroenterol. 2022;56(10):821‐830. doi:10.1097/MCG.0000000000001756
Nobile S, Marchionni P, Meneghin F, et al. Esophageal impedance baseline in infants with bronchopulmonary dysplasia: a pilot study. Pediatr Pulmonol. 2022;57(2):448‐454. doi:10.1002/ppul.25758
Llapur CJ, Martínez MR, Grassino PT, et al. Chronic hypoxia accentuates dysanaptic lung growth. Am J Respir Crit Care Med. 2016;194(3):327‐332. doi:10.1164/rccm.201509‐1851OC
Nelin LD, Kielt MJ, Jebbia M, Jadcherla S, Shepherd EG. Bronchodilator responsiveness and dysanapsis in bronchopulmonary dysplasia. ERJ Open Res. 2022;8(3):00682‐2021. doi:10.1183/23120541.00682‐2021
Hart K, Cousins M, Watkins WJ, Kotecha SJ, Henderson AJ, Kotecha S. Association of early‐life factors with prematurity‐associated lung disease: prospective cohort study. Eur Respir J. 2022;59(5):2101766. doi:10.1183/13993003.01766‐2021
Cousins M, Hart K, Kotecha SJ, et al. Characterising airway obstructive, dysanaptic and PRISm phenotypes of prematurity‐associated lung disease. Thorax. 2023;78:895‐903. doi:10.1136/thorax‐2022‐219301
Duke JW, Lewandowski AJ, Abman SH, Lovering AT. Physiological aspects of cardiopulmonary dysanapsis on exercise in adults born preterm. J Physiol. 2022;600(3):463‐482. doi:10.1113/JP281848
Duke JW, Gladstone IM, Sheel AW, Lovering AT. Premature birth affects the degree of airway dysanapsis and mechanical ventilatory constraints. Exp Physiol. 2018;103(2):261‐275. doi:10.1113/EP086588
Goss KN, Beshish AG, Barton GP, et al. Early pulmonary vascular disease in young adults born preterm. Am J Respir Crit Care Med. 2018;198(12):1549‐1558. doi:10.1164/rccm.201710‐2016OC
Flores‐Fenlon N, Wright N, Lew C, et al. Retrospective analysis of inpatient polysomnogram characteristics and discharge outcomes in infants with bronchopulmonary dysplasia requiring home oxygen therapy. Pediatr Pulmonol. 2021;56(1):88‐96. doi:10.1002/ppul.25129
McGrath‐Morrow SA, Ryan T, McGinley BM, Okelo SO, Sterni LM, Collaco JM. Polysomnography in preterm infants and children with chronic lung disease. Pediatr Pulmonol. 2012;47(2):172‐179. doi:10.1002/ppul.21522
Huang YS, Hsu JF, Paiva T, Chin WC, Chen IC, Guilleminault C. Sleep‐disordered breathing, craniofacial development, and neurodevelopment in premature infants: a 2‐year follow‐up study. Sleep Med. 2019;60:20‐25. doi:10.1016/j.sleep.2018.10.015
Erickson G, Dobson NR, Hunt CE. Immature control of breathing and apnea of prematurity: the known and unknown. J Perinatol. 2021;41(9):2111‐2123. doi:10.1038/s41372‐021‐01010‐z
Kurland G, Deterding RR, Hagood JS, et al. An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy. Am J Respir Crit Care Med. 2013;188(3):376‐394. doi:10.1164/rccm.201305‐0923ST
Dinwiddie R, Sharief N, Crawford O. Idiopathic interstitial pneumonitis in children: a national survey in the United Kingdom and Ireland. Pediatr Pulmonol. 2002;34(1):23‐29. doi:10.1002/ppul.10125
Clement A. Task force on chronic interstitial lung disease in immunocompetent children. Eur Respir J. 2004;24(4):686‐697. doi:10.1183/09031936.04.00089803
Deutsch GH, Young LR, Deterding RR, et al. Diffuse lung disease in young children: application of a novel classification scheme. Am J Respir Crit Care Med. 2007;176(11):1120‐1128. doi:10.1164/rccm.200703‐393OC
Young LR, Brody AS, Inge TH, et al. Neuroendocrine cell distribution and frequency distinguish neuroendocrine cell hyperplasia of infancy from other pulmonary disorders. Chest. 2011;139(5):1060‐1071. doi:10.1378/chest.10‐1304
Long FR, Castile RG. Technique and clinical applications of full‐inflation and end‐exhalation controlled‐ventilation chest CT in infants and young children. Pediatr Radiol. 2001;31(6):413‐422. doi:10.1007/s002470100462
Mahmoud M, Towe C, Fleck RJ. CT chest under general anesthesia: pulmonary, anesthetic and radiologic dilemmas. Pediatr Radiol. 2015;45(7):977‐981. doi:10.1007/s00247‐014‐3250‐3
Chadelat K, Baculard A, Grimfeld A, et al. Pulmonary sarcoidosis in children: serial evaluation of bronchoalveolar lavage cells during corticosteroid treatment. Pediatr Pulmonol. 1993;16(1):41‐47. doi:10.1002/ppul.1950160109
Schapiro AH, Baker ML, Rattan MS, Crotty EJ. Childhood interstitial lung disease more prevalent in infancy: a practical review. Pediatr Radiol. 2022;52(12):2267‐2277. doi:10.1007/s00247‐022‐05375‐x
Nogee LM, Ryan RM. Genetic testing for neonatal respiratory disease. Children (Basel). 2021;8(3):216. doi:10.3390/children8030216
Hamvas A, Chaudhari BP, Nogee LM. Genetic testing for diffuse lung diseases in children. Pediatr Pulmonol. Published online May 16, 2023. doi:10.1002/ppul.26447
Langston C, Patterson K, Dishop MK, et al. A protocol for the handling of tissue obtained by operative lung biopsy: recommendations of the chILD pathology co‐operative group. Pediatr Dev Pathol. 2006;9(3):173‐180. doi:10.2350/06‐03‐0065.1
Liang T, Vargas SO, Lee EY. Childhood interstitial (diffuse) lung disease: pattern recognition approach to diagnosis in infants. Am J Roentgenol. 2019;212(5):958‐967. doi:10.2214/AJR.18.20696
Young LR. Uptodate: approach to the infant and child with diffuse lung disease (interstitial lung disease). 2023. Accessed Oct 5, 2023. https://www.uptodate.com/contents/approach‐to‐the‐infant‐and‐child‐with‐diffuse‐lung‐disease‐interstitial‐lung‐disease?search=Approach%20to%20the%20infant%20and%20child%20with%20diffuse%20lung%20disease.%20UpToDate,2023.%20§ionRank=2&usage_type=default&anchor=H113683686&source=machineLearning&selectedTitle=1~150&display_rank=1#H113683686
Hillman NH. Increasing pulmonary blood flow at birth: the nerve of the baby. J Physiol. 2017;595(5):1437‐1438. doi:10.1113/JP273783
Rosenzweig EB, Abman SH, Adatia I, et al. Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management. Eur Respir J. 2019;53(1):1801916. doi:10.1183/13993003.01916‐2018
Abman SH, Hansmann G, Archer SL, et al. Pediatric pulmonary hypertension: guidelines from the American Heart Association and American Thoracic Society. Circulation. 2015;132(21):2037‐2099. doi:10.1161/CIR.0000000000000329
Del Cerro MJ, Moledina S, Haworth SG, et al. Cardiac catheterization in children with pulmonary hypertensive vascular disease: consensus statement from the Pulmonary Vascular Research Institute, Pediatric and Congenital Heart Disease Task Forces. Pulm Circ. 2016;6(1):118‐125. doi:10.1086/685102
Frank BS, Schäfer M, Grenolds A, Ivy DD, Abman SH, Darst JR. Acute vasoreactivity testing during cardiac catheterization of neonates with bronchopulmonary dysplasia‐associated pulmonary hypertension. J Pediatr. 2019;208:127‐133. doi:10.1016/j.jpeds.2018.12.004
Douglas NJ. Control of ventilation during sleep. Clin Chest Med. 1985;6(4):563‐575.
Alvaro RE. Control of breathing and apnea of prematurity. NeoReviews. 2018;19(4):e224‐e234.
Al‐Matary A, Kutbi I, Qurashi M, et al. Increased peripheral chemoreceptor activity may be critical in destabilizing breathing in neonates. Semin Perinatol. 2004;28(4):264‐272. doi:10.1053/j.semperi.2004.08.003
Chandrasekar I, Tablizo MA, Witmans M, Cruz JM, Cummins M, Estrellado‐Cruz W. Obstructive sleep apnea in neonates. Children (Basel). 2022;9(3):419. doi:10.3390/children9030419
Edwards BA, Sands SA, Berger PJ. Postnatal maturation of breathing stability and loop gain: the role of carotid chemoreceptor development. Respir Physiol Neurobiol. 2013;185(1):144‐155. doi:10.1016/j.resp.2012.06.003
Brockbank J, Leon‐Astudillo C, Che D, et al. Supplemental oxygen for treatment of infants with obstructive sleep apnea. J Clin Sleep Med. 2019;15(8):1115‐1123. doi:10.5664/jcsm.7802
Katz ES, Mitchell RB, D'Ambrosio CM. Obstructive sleep apnea in infants. Am J Respir Crit Care Med. 2012;185(8):805‐816. doi:10.1164/rccm.201108‐1455CI
Troester MMQS, Berry RB, American Academy of Sleep Medicine. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications. Version 3. American Academy of Sleep Medicine; 2023.
McLaren AT, Bin‐Hasan S, Narang I. Diagnosis, management and pathophysiology of central sleep apnea in children. Paediatr Respir Rev. 2019;30:49‐57. doi:10.1016/j.prrv.2018.07.005
Sateia MJ. International classification of sleep disorders‐third edition. Chest. 2014;146(5):1387‐1394. doi:10.1378/chest.14‐0970
Eichenwald EC, Watterberg KL, Aucott S, et al. Committee on fetus and newborn, american academy of pediatrics. Apnea of prematurity. Pediatrics. Published online December 1, 2015. 2016;137(1). doi:10.1542/peds.2015‐3757
Seppä‐Moilanen M, Andersson S, Kirjavainen T. Supplemental oxygen treats periodic breathing without effects on sleep in late‐preterm infants. Neonatology. 2022;119(5):567‐574. doi:10.1159/000525196
Lemyre B, Davis PG, De Paoli AG. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for apnea of prematurity. Cochrane Database Syst Rev. 2000;3:CD002272. doi:10.1002/14651858.CD002272
Sabsabi B, Harrison A, Banfield L, Mukerji A. Nasal intermittent positive pressure ventilation versus continuous positive airway pressure and apnea of prematurity: a systematic review and meta‐analysis. Am J Perinatol. 2022;39(12):1314‐1320. doi:10.1055/s‐0040‐1722337
Daftary AS, Jalou HE, Shively L, Slaven JE, Davis SD. Polysomnography reference values in healthy newborns. J Clin Sleep Med. 2019;15(3):437‐443. doi:10.5664/jcsm.7670
Brockmann PE, Poets A, Poets CF. Reference values for respiratory events in overnight polygraphy from infants aged 1 and 3months. Sleep Med. 2013;14(12):1323‐1327. doi:10.1016/j.sleep.2013.07.016
Stefanovski D, Tapia IE, Lioy J, et al. Respiratory indices during sleep in healthy infants: a prospective longitudinal study and meta‐analysis. Sleep Med. 2022;99:49‐57. doi:10.1016/j.sleep.2022.07.010
Vézina K, Mariasine J, Young R, et al. Cardiorespiratory monitoring data during sleep in healthy Canadian infants. Ann Am Thorac Soc. 2020;17(10):1238‐1246. doi:10.1513/AnnalsATS.201909‐703OC
Urquhart DS, Hill EA, Morley A. Sleep‐disordered breathing in children. Paediatrics Child Health. 2017;27(7):328‐336. doi:10.1016/j.paed.2017.03.004
Weese‐Mayer DE, Berry‐Kravis EM, Ceccherini I, Keens TG, Loghmanee DA, Trang H. An official ATS clinical policy statement: congenital central hypoventilation syndrome: genetic basis, diagnosis, and management. Am J Respir Crit Care Med. 2010;181(6):626‐644. doi:10.1164/rccm.200807‐1069ST
Maloney MA, Kun SS, Keens TG, Perez IA. Congenital central hypoventilation syndrome: diagnosis and management. Expert Rev Resp Med. 2018;12(4):283‐292. doi:10.1080/17476348.2018.1445970
Trang H, Samuels M, Ceccherini I, et al. Guidelines for diagnosis and management of congenital central hypoventilation syndrome. Orphanet J Rare Dis. 2020;15(1):252. doi:10.1186/s13023‐020‐01460‐2
Paton JY, Swaminathan S, Sargent CW, Keens TG. Hypoxic and hypercapnic ventilatory responses in awake children with congenital central hypoventilation syndrome. Am Rev Respir Dis. 1989;140(2):368‐372. doi:10.1164/ajrccm/140.2.368
Montgomery‐Downs HE, Gozal D. Sleep habits and risk factors for sleep‐disordered breathing in infants and young toddlers in Louisville, Kentucky. Sleep Med. 2006;7(3):211‐219. doi:10.1016/j.sleep.2005.11.003
Leon‐Astudillo C, Wagner M, Salabarria SM, et al. Polysomnography findings in children with spinal muscular atrophy after onasemnogene‐abeparvovec. Sleep Med. 2023;101:234‐237. doi:10.1016/j.sleep.2022.11.006
Kansagra S, Austin S, DeArmey S, Kazi Z, Kravitz RM, Kishnani PS. Longitudinal polysomnographic findings in infantile Pompe disease. Am J Med Genet, Part A. 2015;167A(4):858‐861. doi:10.1002/ajmg.a.37007
Chiang J, Xiao L, Nigro E, et al. Sleep disordered breathing in infants identified through newborn screening with spinal muscular atrophy. Sleep Med. 2023;111:161‐169. doi:10.1016/j.sleep.2023.09.019
Slocum C, Hibbs AM, Martin RJ, Orenstein SR. Infant apnea and gastroesophageal reflux: a critical review and framework for further investigation. Curr Gastroenterol Rep. 2007;9(3):219‐224. doi:10.1007/s11894‐007‐0022‐3
Greenfeld M, Tauman R, DeRowe A, Sivan Y. Obstructive sleep apnea syndrome due to adenotonsillar hypertrophy in infants. Int J Pediatr Otorhinolaryngol. 2003;67(10):1055‐1060. doi:10.1016/s0165‐5876(03)00182‐4
Bhattacharjee R, Kheirandish‐Gozal L, Spruyt K, et al. Adenotonsillectomy outcomes in treatment of obstructive sleep apnea in children: a multicenter retrospective study. Am J Respir Crit Care Med. 2010;182(5):676‐683. doi:10.1164/rccm.200912‐1930OC
Williamson A, Ibrahim SR, Coutras SW, Carr MM. Pediatric drug‐induced sleep endoscopy: technique and scoring system. Cureus. 2020;12(10):e10765. doi:10.7759/cureus.10765
Li C, Kou YF, DeMarcantonio MA, et al. Sleep endoscopy and cine magnetic resonance imaging evaluation of children with persistent obstructive sleep apnea. Otolaryngol–Head Neck Surg. 2023;168(4):848‐855. doi:10.1177/01945998221097659
Salmone RJ, Van Lunteren E. Effects of hypoxia and hypercapnia on geniohyoid contractility and endurance. J Appl Physiol. 1991;71(2):709‐715. doi:10.1152/jappl.1991.71.2.709
Wellman A, Malhotra A, Jordan AS, Stevenson KE, Gautam S, White DP. Effect of oxygen in obstructive sleep apnea: role of loop gain. Respir Physiol Neurobiol. 2008;162(2):144‐151. doi:10.1016/j.resp.2008.05.019
Aurora RN, Zak RS, Karippot A, et al. Practice parameters for the respiratory indications for polysomnography in children. Sleep. 2011;34(3):379‐388. doi:10.1093/sleep/34.3.379
McNamara F, Sullivan CE. Obstructive sleep apnea in infants and its management with nasal continuous positive airway pressure. Chest. 1999;116(1):10‐16. doi:10.1378/chest.116.1.10
Cielo CM, Hernandez P, Ciampaglia AM, Xanthopoulos MS, Beck SE, Tapia IE. Positive airway pressure for the treatment of OSA in infants. Chest. 2021;159(2):810‐817. doi:10.1016/j.chest.2020.08.020
Bariani RCB, Guimarães TM, Cappellette M, Moreira G, Fujita RR. The impact of positive airway pressure on midface growth: a literature review. Brazilian J Otorhinolaryngol. 2020;86(5):647‐653. doi:10.1016/j.bjorl.2020.05.010
Massa F. The use of nasal continuous positive airway pressure to treat obstructive sleep apnoea. Arch Dis Child. 2002;87(5):438‐443. doi:10.1136/adc.87.5.438